Literature DB >> 14569263

Spinal cord lesion management in Italy: a 2-year survey.

M C Pagliacci1, M G Celani, L Spizzichino, M Zampolini, S Aito, A Citterio, G Finali, D Loria, S Ricci, M Taricco, M Franceschini.   

Abstract

DESIGN: Prospective 2-year survey from 1 February 1997 to 31 January 1999.
OBJECTIVES: To compare the route from injury to rehabilitation, and the outcome of care in a large sample of traumatic (T) and nontraumatic (NT) spinal cord lesion (SCL) patients at their 'first admission'.
SETTING: T and NT SCI patients consecutively admitted to 37 SCL centres in Italy.
METHOD: Data were recorded on simple, computerised, closed-question forms, which were Centrally collected and analysed. Descriptive and inferential analysis was conducted to define the characteristics and compare the T and NT populations, and to identify correlations among the variables examined: time from the event to admission (TEA); pressure sores (PS) on admission; length of stay (LoS) and destination on discharge.
RESULTS: A total of 1014 SCL patients, 67.5% with a lesion of T and 32.5% of NT aetiology were analysed. The subjects in the T group were younger (median 34 versus 58 years), with higher probability of cervical involvement (OR 2.47, CI 1.8-3.4) and completeness of the lesion (OR 3.0, CI 2.3-4.0), shorter median TEA (37 versus 64 days, P<0.0001) and less frequent admission from home (3.6 versus 17.4%) compared to the NT group. TEA and PS on admission were analysed as indicators of the efficacy of the courses from injury to rehabilitation. Longer TEA was reported for people with NT aetiology, admitted to rehabilitation centre (RC), not locally resident, transferred from certain wards and to a lesser degree female subjects and those with complications on admission. PS were associated to completeness of lesion, longer TEA, admission to RC, nonlocal residence and coming from general intensive care units, or general surgery wards. Median LoS was 99 days (mean 116 and range 0-672), and was statistically shorter in the NT group (122 versus 57 median, P<0.00001). Upon discharge, bladder and bowel autonomy were, respectively, obtained in 68.1 and 64.5% of the whole population without significant difference between the T and NT groups. A total of 80.2% of patients were discharged home and the following factors: not living alone, being discharged after longer LoS, having sphincterial autonomy and no PS, were all independent predictors of outcome.
CONCLUSION: There are important obstacles in the admission route to rehabilitation facilities, greater for NT, as longer TEA and more complications on admission testify. Moreover, the LoS is shorter for NT population. Our findings suggest that rehabilitation outcome could be improved through an early multidisciplinary approach and better continuity between acute and rehabilitation care, especially for the 'neglected' NT SCL patients.

Entities:  

Mesh:

Year:  2003        PMID: 14569263     DOI: 10.1038/sj.sc.3101521

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  17 in total

1.  Prediction Model for the Presence of Complications at Admission to Rehabilitation After Traumatic Spinal Cord Injury.

Authors:  Giorgio Scivoletto; Monica Torre; Marco Iosa; Maria Rosaria Porto; Marco Molinari
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017-11-17

2.  Prospective study of barriers to discharge from a spinal cord injury rehabilitation unit.

Authors:  P W New
Journal:  Spinal Cord       Date:  2014-09-30       Impact factor: 2.772

3.  The SCIRehab project: treatment time spent in SCI rehabilitation. Inpatient treatment time across disciplines in spinal cord injury rehabilitation.

Authors:  Gale Whiteneck; Julie Gassaway; Marcel Dijkers; Deborah Backus; Susan Charlifue; David Chen; Flora Hammond; Ching-Hui Hsieh; Randall J Smout
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

4.  Emotional Consequences of Delays in Spinal Rehabilitation Unit Admission or Discharge: A Qualitative Study on the Importance of Communication.

Authors:  Narelle Warren; Karin Walford; Annisha Susilo; Peter Wayne New
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017-09-27

5.  Incidence of traumatic spinal cord injury in Italy during 2013-2014: a population-based study.

Authors:  S Ferro; L Cecconi; J Bonavita; M C Pagliacci; A Biggeri; M Franceschini
Journal:  Spinal Cord       Date:  2017-09-05       Impact factor: 2.772

6.  Cross-cultural adaptation and validation of the "Spinal Cord Injury-Falls Concern Scale" in the Italian population.

Authors:  Maria Auxiliadora Marquez; Rita De Santis; Viviana Ammendola; Martina Antonacci; Valter Santilli; Anna Berardi; Donatella Valente; Giovanni Galeoto
Journal:  Spinal Cord       Date:  2018-02-15       Impact factor: 2.772

7.  Walking-related outcomes for individuals with traumatic and non-traumatic spinal cord injury inform physical therapy practice.

Authors:  Andresa R Marinho; Heather M Flett; Catharine Craven; C Andrea Ottensmeyer; Daria Parsons; Molly C Verrier
Journal:  J Spinal Cord Med       Date:  2012-09       Impact factor: 1.985

8.  Rehabilitation of patients with nontraumatic spinal cord injury in the Netherlands: etiology, length of stay, and functional outcome.

Authors:  Jolien J Vervoordeldonk; Marcel W M Post; Peter New; M Clin Epi; Floris W A Van Asbeck
Journal:  Top Spinal Cord Inj Rehabil       Date:  2013

9.  Observational study of the effectiveness of spinal cord injury rehabilitation using the Spinal Cord Injury-Ability Realization Measurement Index.

Authors:  G Scivoletto; J Bonavita; M Torre; I Baroncini; S Tiberti; E Maietti; L Laurenza; S China; V Corallo; F Guerra; L Buscaroli; C Candeloro; E Brunelli; A Catz; M Molinari
Journal:  Spinal Cord       Date:  2015-09-15       Impact factor: 2.772

10.  New approach to study the contents and outcomes of spinal cord injury rehabilitation: the SCIRehab Project.

Authors:  Gale Whiteneck; Julie Gassaway; Marcel Dijkers; Amitabh Jha
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.